# Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adalimumab-therapy-for-moderate-to-severe-psoriasis-a-randomized-controlled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alan Menter,Stephen K. Tyring,Kenneth B. Gordon,Alexa B. Kimball,Craig L. Leonardi,Richard G. Langley,Bruce Strober,Martin Kaul,Yihua Gu,Martin M. Okun,Kim Papp |
| Citations | 886 |
| DOI | 10.1016/j.jaad.2007.09.010 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2063627867 |
| PMID | 17936411 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Alexa B. Kimball](https://scholariq.org/researchers/alexa-b-kimball/)
- [Bruce Strober](https://scholariq.org/researchers/bruce-strober/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Hidradenitis Suppurativa and Treatments](https://scholariq.org/topics/hidradenitis-suppurativa-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.